Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Improving Mood and Cognitive Symptoms in Huntington's Disease With Cariprazine Treatment
Mária Judit Molnár, Viktor Molnár, Mariann Fedor, et al.
Frontiers in Psychiatry (2022) Vol. 12
Open Access | Times Cited: 17

Showing 17 citing articles:

A randomized clinical trial to evaluate the efficacy of cognitive rehabilitation and music therapy in mild cognitive impairment in Huntington’s disease
Andrea Moreu-Valls, Arnau Puig‐Davi, Saül Martínez‐Horta, et al.
Journal of Neurology (2025) Vol. 272, Iss. 3
Closed Access | Times Cited: 1
Treatment of Depression in Huntington’s Disease: A Systematic Review
Shayan Abdollah Zadegan, Frank Ramirez, Kirthan S. Reddy, et al.
Journal of Neuropsychiatry (2024)
Closed Access | Times Cited: 6
Symptomatic treatment options for Huntington’s disease (guidelines of the German Neurological Society)
Carsten Saft, Jean‐Marc Burgunder, M. Dose, et al.
Neurological Research and Practice (2023) Vol. 5, Iss. 1
Open Access | Times Cited: 14
The pathobiology of depression in Huntington’s disease: an unresolved puzzle
K. A. Jellinger
Journal of Neural Transmission (2024)
Closed Access | Times Cited: 4
Role of Serotonergic System in Regulating Brain Tumor-Associated Neuroinflammatory Responses
Surojit Karmakar, Girdhari Lal
Methods in molecular biology (2024), pp. 181-207
Closed Access | Times Cited: 4
Pharmacological Treatment of Neuropsychiatric Symptoms in Huntington's Disease: A Systematic Review
Ruben Andriessen, Mayke Oosterloo, Jory Molema, et al.
Movement Disorders Clinical Practice (2025)
Open Access
Multilevel evidence of MECP2-associated mitochondrial dysfunction and its therapeutic implications
Péter Balicza, András Gézsi, Mariann Fedor, et al.
Frontiers in Psychiatry (2024) Vol. 14
Open Access | Times Cited: 3
Treatments and regulatory mechanisms of acoustic stimuli on mood disorders and neurological diseases
Yi‐Kai Chen, Julianne Sun, Junxian Tao, et al.
Frontiers in Neuroscience (2024) Vol. 17
Open Access | Times Cited: 2
Pathomechanisms of behavioral abnormalities in Huntington disease: an update
K. A. Jellinger
Journal of Neural Transmission (2024) Vol. 131, Iss. 9, pp. 999-1012
Closed Access | Times Cited: 2
Differentiating the third generation of antipsychotics: a focus on lumateperone’s similarities and differences
Gloria Munayco Maldonado, Thomas L. Schwartz
International Clinical Psychopharmacology (2023) Vol. 39, Iss. 1, pp. 4-16
Closed Access | Times Cited: 6
The improvement of motor symptoms in Huntington’s disease during cariprazine treatment
Réka Csehi, Viktor Molnár, Mariann Fedor, et al.
Orphanet Journal of Rare Diseases (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 4
Occupational exposure to polychlorinated biphenyls: Development of neuropsychological functions over time
Julia L. Cromberg, Thomas Schettgen, Klaus Willmes, et al.
NeuroToxicology (2024) Vol. 101, pp. 6-15
Open Access
Neuropsychology and Movement Disorders
Julia Adeney Thomas, Alexander I. Tröster
Neurologic Clinics (2024) Vol. 42, Iss. 4, pp. 821-833
Closed Access
Guidance on antipsychotic selection for agitation and aggressive behavior in persons with Huntington’s disease
James Eaton, Daniel O. Claassen
Expert Review of Neurotherapeutics (2024) Vol. 24, Iss. 10, pp. 937-940
Closed Access
Evidence-Based Review on Symptomatic Management of Huntington’s Disease
Jung Hwan Shin, Hui-Jun Yang, Jong‐Hyun Ahn, et al.
Journal of Movement Disorders (2024) Vol. 17, Iss. 4, pp. 369-386
Open Access
The Polypharmacology of Cariprazine and its Implications to Clinical Indications
Attila Egyed, Dóra Kiss, György M. Keserü
(2024), pp. 385-404
Closed Access
The improvement of motor symptoms in Huntington’s disease during cariprazine treatment
Réka Csehi, Viktor Molnár, Mariann Fedor, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top